Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    002603   CNE1000015S0

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

(002603)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021

04/28/2021 | 05:39am EST

Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 3,668.399 million compared to CNY 2,333.599 million a year ago. Operating income was CNY 825.185 million compared to CNY 522.964 million a year ago. Net income was CNY 674.687 million compared to CNY 437.974 million a year ago. Basic earnings per share from continuing operations was CNY 0.57 compared to CNY 0.37 a year ago.


ę S&P Capital IQ 2021
All news about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2021HS Bio Sdn. Bhd. Enters into MOU with Shijiazhuang Yiling Pharmaceutical Co., Ltd
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces 2020 Final Distribution Plan to ..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Dividend for the Year 2020
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year..
CI
2021SHIJIAZHUANG YILING PHARMACEUTICAL : Yiling Pharmaceutical Wins Nod to Market COVID-19 Her..
MT
More news
Financials
Sales 2021 11 530 M 1 819 M 1 819 M
Net income 2021 1 675 M 264 M 264 M
Net Debt 2021 - - -
P/E ratio 2021 20,0x
Yield 2021 -
Capitalization 37 825 M 5 967 M 5 967 M
Capi. / Sales 2021 3,28x
Capi. / Sales 2022 2,73x
Nbr of Employees 16 912
Free-Float 40,9%
Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Duration : Period :
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Technical Analysis Chart | 002603 | CNE1000015S0 | MarketScreener
Technical analysis trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 22,64 CNY
Average target price 21,04 CNY
Spread / Average Target -7,07%
EPS Revisions
Managers and Directors
Xiang Jun Wu Director & General Manager-Marketing Center
Chen Guang Li Chief Financial Officer & Director
Yi Ling Wu Chairman
Xue Dong Gao Chairman-Supervisory Board
Zhen Wang Independent Director